ArticleDiabetes2026
HGF Endogenously Produced by Pancreatic Pericytes Regulates β-Cell Function.
Article in Diabetes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Hepatocyte growth factor (HGF)/c-Met signaling is a well-established pathway through which external signals regulate β-cell resilience and function. Yet the endogenous source of HGF in the islets and its physiological role in this context remain unclear. Here, we combined human islet single-cell transcriptomics with mouse pancreatic-cell profiling to show that pericytes, rather than endothelial cells, are the primary source of HGF in healthy islets. Using transgenic mouse tools and culture systems, we found that pericyte-derived HGF is required for β-cell function and glucose homeostasis. Adult mice lacking pericytic HGF in their pancreata developed glucose intolerance while maintaining β-cell mass and insulin sensitivity. Mechanistically, HGF secreted by pancreatic pericytes is required for proper insulin production and secretion by regulating the expression of key β-cell genes, including Pdx1, Slc2a2, and Ins1. In addition, neonatal and pregnant mice lacking mesenchymal/pericytic HGF had lower β-cell mass, indicating its context-dependent requirement for β-cell expansion. Thus, we suggest that pericytic HGF is required for insulin production and secretion during homeostasis and for supporting β-cell expansion during embryogenesis and pregnancy. Together, our findings establish pericytes as a significant endogenous source of HGF, coupling the islet microvasculature to insulin production and glucose homeostasis. ARTICLE HIGHLIGHTS: Despite extensive research on the role of the hepatocyte growth factor (HGF)/c-Met pathway in β-cells and glucose homeostasis, the endogenous source of HGF in islets remains unclear. This study characterizes the pancreatic source of HGF and its physiological requirement in vivo. Pericytes were identified as the primary endogenous source of HGF in human and mouse islets. Pericytic HGF loss causes glucose intolerance by impairing insulin production through the regulation of key β-cell genes. Establishing β-cell mass during embryogenesis and pregnancy depends on mesenchymal/pericytic HGF. This study establishes the islet vasculature as a source of trophic factors required for glycemic control.
Indexed as
Identifiers
42616555What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.